Home » Abbott’s Drug to Enter Phase II Trial in Singapore
Abbott’s Drug to Enter Phase II Trial in Singapore
A team of physician scientists from several hospitals in Singapore has successfully completed the phase I trial of a “small molecule” drug for treating advanced stages of lung cancer and other forms of cancer.
Biospectrum
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May